Alnylam Pharmaceuticals shares owned by Hudson Bay Capital Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Hudson Bay Capital Management
from 13F filings
Historical chart of Hudson Bay Capital Management investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Hudson Bay Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $5.0M | 18k | 275.03 |
| 2024-06-30 | $30M | 125k | 243.00 |
| 2024-03-31 | $23M | 153k | 149.45 |
| 2023-12-31 | $16M | 83k | 191.41 |
| 2023-09-30 | $12M | 66k | 177.10 |
| 2020-12-31 | $2.6M | 20k | 129.95 |
| 2019-12-31 | $6.9M | 60k | 115.17 |
| 2019-09-30 | $4.8M | 60k | 80.41 |
| 2019-06-30 | $16M | 215k | 72.56 |
| 2019-03-31 | $4.7M | 50k | 93.46 |
| 2018-12-31 | $4.0M | 55k | 72.91 |
| 2018-09-30 | $5.3M | 60k | 87.52 |
| 2018-06-30 | $3.0M | 30k | 98.50 |
More positions owned by Hudson Bay Capital Management
View all positions for Hudson Bay Capital Management